Thomas Malley, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), bought 10,000 shares at $16.00 ($160K) on 2012-10-24, disclosed to the SEC on 2012-10-25.
Open-market purchase of $160k PBYI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BGNE | BUY | 2016-11-28 | $960K | — | Filing → |
| KURA | BUY | 2015-12-17 | $400K | — | Filing → |
| OVAS | BUY | 2015-04-09 | $143K | — | Filing → |